BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35855660)

  • 1. Fertility preservation for patients with melanoma.
    Filippi F; Serra N; Vigano P; Boeri L; Cimminiello C; Di Guardo L; Somigliana E; Del Vecchio M
    Melanoma Res; 2022 Oct; 32(5):303-308. PubMed ID: 35855660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility preservation and management of pregnancy in melanoma patients requiring systemic therapy.
    Hassel JC; Livingstone E; Allam JP; Behre HM; Bojunga J; Klein HH; Landsberg J; Nawroth F; Schüring A; Susok L; Thoms KM; Kiesel L; Berking C
    ESMO Open; 2021 Oct; 6(5):100248. PubMed ID: 34438241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fertility preservation in cancer survivors.
    Winkler-Crepaz K; Ayuandari S; Ziehr SC; Hofer S; Wildt L
    Minerva Endocrinol; 2015 Jun; 40(2):105-18. PubMed ID: 25614989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility preservation in the male pediatric population: factors influencing the decision of parents and children.
    Wyns C; Collienne C; Shenfield F; Robert A; Laurent P; Roegiers L; Brichard B
    Hum Reprod; 2015 Sep; 30(9):2022-30. PubMed ID: 26141713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncofertility considerations in adolescents and young adults given a diagnosis of melanoma: Fertility risk of Food and Drug Administration-approved systemic therapies.
    Walter JR; Xu S; Paller AS; Choi JN; Woodruff TK
    J Am Acad Dermatol; 2016 Sep; 75(3):528-534. PubMed ID: 27543212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer and fertility preservation: international recommendations from an expert meeting.
    Lambertini M; Del Mastro L; Pescio MC; Andersen CY; Azim HA; Peccatori FA; Costa M; Revelli A; Salvagno F; Gennari A; Ubaldi FM; La Sala GB; De Stefano C; Wallace WH; Partridge AH; Anserini P
    BMC Med; 2016 Jan; 14():1. PubMed ID: 26728489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Considerations and Systemic Therapy of Melanoma.
    Gamboa AC; Lowe M; Yushak ML; Delman KA
    Surg Clin North Am; 2020 Feb; 100(1):141-159. PubMed ID: 31753109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of Reproductive Experiences and Outcomes of Cancer Survivors Who Stored Reproductive Material Before Treatment.
    Hammarberg K; Kirkman M; Stern C; McLachlan RI; Clarke G; Agresta F; Gook D; Rombauts L; Vollenhoven B; Fisher JRW
    Hum Reprod; 2017 Dec; 32(12):2423-2430. PubMed ID: 29045667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women more vulnerable than men when facing risk for treatment-induced infertility: a qualitative study of young adults newly diagnosed with cancer.
    Armuand GM; Wettergren L; Rodriguez-Wallberg KA; Lampic C
    Acta Oncol; 2015 Feb; 54(2):243-52. PubMed ID: 25140859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (Neo)adjuvant systemic therapy for melanoma.
    van Zeijl MC; van den Eertwegh AJ; Haanen JB; Wouters MW
    Eur J Surg Oncol; 2017 Mar; 43(3):534-543. PubMed ID: 27453302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SEOM Clinical Guideline of fertility preservation and reproduction in cancer patients (2016).
    Muñoz M; Santaballa A; Seguí MA; Beato C; de la Cruz S; Espinosa J; Fonseca PJ; Perez J; Quintanar T; Blasco A
    Clin Transl Oncol; 2016 Dec; 18(12):1229-1236. PubMed ID: 27896641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do cancer therapies damage the uterus and compromise fertility?
    Griffiths MJ; Winship AL; Hutt KJ
    Hum Reprod Update; 2020 Feb; 26(2):161-173. PubMed ID: 31863097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?
    Jones G; Hughes J; Mahmoodi N; Smith E; Skull J; Ledger W
    Hum Reprod Update; 2017 Jul; 23(4):433-457. PubMed ID: 28510760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of boys who have undergone a testicular biopsy for fertility preservation.
    Kanbar M; de Michele F; Giudice MG; Desmet L; Poels J; Wyns C
    Hum Reprod; 2021 Jan; 36(1):26-39. PubMed ID: 33259629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving survival in patients with high-risk and metastatic melanoma: immunotherapy leads the way.
    Agarwala S
    Am J Clin Dermatol; 2003; 4(5):333-46. PubMed ID: 12688838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for Melanoma.
    Albittar AA; Alhalabi O; Glitza Oliva IC
    Adv Exp Med Biol; 2020; 1244():51-68. PubMed ID: 32301010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Melanoma.
    Glitza Oliva IC; Alqusairi R
    Adv Exp Med Biol; 2018; 995():43-63. PubMed ID: 30539505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for melanoma.
    Kim CJ; Dessureault S; Gabrilovich D; Reintgen DS; Slingluff CL
    Cancer Control; 2002; 9(1):22-30. PubMed ID: 11907463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and options for systemic therapy in melanoma.
    Sondak VK; Gibney GT
    Surg Clin North Am; 2014 Oct; 94(5):1049-58, viii. PubMed ID: 25245967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fertility preservation in oncology].
    Chaput L; Grémeau AS; Vorilhon S; Pons H; Chabrot C; Grèze V; Pouly JL; Brugnon F
    Bull Cancer; 2018 Jan; 105(1):99-110. PubMed ID: 29221621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.